Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. The Development of Screening Guidelines and Clinical Criteria of Predementia Alzheimer's Disease (DESCRIPA) multicenter study enrolled patients with MCI or subjective cognitive complaints (SUBJ), a part of whom underwent optional brain perfusion SPECT. These patients were classified as SUBJ (n = 23), nonamnestic MCI (naMCI n = 17) and amnestic MCI (aMCI